Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Extranodal NK-T-Cell × Etoposide × 90 days × Clear all

Sponsor

Conditions

Small Cell Lung Carcinoma 18 Lymphoma, Large B-Cell, Diffuse 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Medulloblastoma 7 Lung Neoplasms 7 Burkitt Lymphoma 7 Lymphoma 6 Leukemia, Myeloid, Acute 6 Sarcoma, Ewing 5 Recurrence 5 Brain Neoplasms 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasms 4 Hodgkin Disease 4 Ependymoma 4 Carcinoma, Non-Small-Cell Lung 4 Neuroblastoma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Lymphoma, B-Cell 3 Glioblastoma 3 Wilms Tumor 2 Teratoma 2 Sarcoma 2 Rhabdoid Tumor 2 Osteosarcoma 2 Neuroendocrine Tumors 2 Neoplasms, Germ Cell and Embryonal 2 Leukemia 2 Glioma 2

Interventions

pegaspargase 3 tislelizumab 1 sugemalimab 1 relatlimab 1 gemcitabine-oxaliplatin regimen 1 Vorinostat 1 Valganciclovir 1 Therapeutics 1 Polymerase Chain Reaction 1 Oxaliplatin 1 Nivolumab 1 Immune Checkpoint Inhibitors 1 Ice 1 Gemcitabine 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Cholecalciferol 1 Azacitidine 1 Antiviral Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡